Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 16 January 2024 31 January 2025 31 January 2025 15416951 Yousif Barr iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15416951 2024-01-15 15416951 2025-01-31 15416951 2024-01-16 2025-01-31 15416951 frs-core:CurrentFinancialInstruments 2025-01-31 15416951 frs-bus:PrivateLimitedCompanyLtd 2024-01-16 2025-01-31 15416951 frs-bus:FilletedAccounts 2024-01-16 2025-01-31 15416951 frs-bus:Micro-entities 2024-01-16 2025-01-31 15416951 frs-bus:AuditExempt-NoAccountantsReport 2024-01-16 2025-01-31 15416951 frs-bus:Director1 2024-01-16 2025-01-31
Registered number: 15416951
YB Osteopathy Ltd
Unaudited Financial Statements
For the Period 16 January 2024 to 31 January 2025
YB Osteopathy Ltd
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 15416951

| 31 January 2025
--- | ---
|  | £
Current assets |  | 3,861
Creditors: Amounts Falling Due Within One Year |  | (2,930 )
NET CURRENT ASSETS |  | 931
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 931
Accruals and deferred income |  | (299 )
NET ASSETS |  | 632
CAPITAL AND RESERVES |  | 632

## Notes

1. General Information
YB Osteopathy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15416951 . The registered office is Flat 10 Cloisters Court, 77 Cromwell Avenue, London, N6 5XG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Yousif Barr Director
15th October 2025